# Dose Finding Study in COPD

> **NCT00122434** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 389 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** BEA 2180 BR
- **DRUG:** tiotropium

## Key facts

- **NCT ID:** NCT00122434
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2006-05
- **Final completion:** —
- **Target enrollment:** 389 (ACTUAL)
- **Last updated:** 2017-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00122434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00122434, "Dose Finding Study in COPD". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00122434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*